---
title: "The country's first group standard for the \"Technical Guidelines for Non-Clinical Safety of Oligonucleotide Drugs\" has been released"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257842041.md"
description: "The 9th China Nucleic Acid Drug Conference opened in Tianjin on September 17. The Tianjin Economic and Technological Development Zone Nucleic Acid Pharmaceutical Industry Park and the Tianjin Nucleic Acid Industry Innovation Service Center were officially inaugurated, and the country's first group standard for the \"Technical Guidelines for Non-Clinical Safety of Oligonucleotide Drugs\" was released. Three key projects were signed on-site, with a cooperation scale exceeding 100 million yuan, covering areas such as the construction of production and manufacturing bases, development of new nucleic acid drugs and vaccines, and research and development of coronary artery-like organ nucleic acid drugs"
datetime: "2025-09-18T05:54:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257842041.md)
  - [en](https://longbridge.com/en/news/257842041.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257842041.md)
generator: "portal-rs"
---

# The country's first group standard for the "Technical Guidelines for Non-Clinical Safety of Oligonucleotide Drugs" has been released

The 9th China Nucleic Acid Drug Conference opened in Tianjin on September 17. The Tianjin Economic and Technological Development Zone Nucleic Acid Pharmaceutical Industrial Park and the Tianjin Nucleic Acid Industry Innovation Service Center were officially inaugurated, and the country's first group standard for the "Technical Guidelines for Non-Clinical Safety of Oligonucleotide Drugs" was released. Three key projects were signed on-site, with a cooperation scale exceeding 100 million yuan, covering areas such as the construction of production and manufacturing bases, development of new nucleic acid drugs and vaccines, and research and development of coronary artery-like organ nucleic acid drugs

### Related Stocks

- [603392.CN](https://longbridge.com/en/quote/603392.CN.md)
- [300142.CN](https://longbridge.com/en/quote/300142.CN.md)
- [688185.CN](https://longbridge.com/en/quote/688185.CN.md)
- [06185.HK](https://longbridge.com/en/quote/06185.HK.md)

## Related News & Research

- [Hybrid Power Solutions Inc. Files Patent Application for Advanced AI-Powered Energy Management System](https://longbridge.com/en/news/297787562.md)
- [12:09 ETHaier Biomedical präsentiert automatisierte Biolagerung und vernetzte Pharma-Lösungen auf der ISPE Singapore 2026](https://longbridge.com/en/news/297810393.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)
- [Coast Copper completes purchase of mineral tenure adjacent to Copper Kettle property](https://longbridge.com/en/news/297959335.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**